Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Janssen-Cilag Ltd
50 - 100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG
Telephone: +44 (0)1494 567 567
Fax: +44 (0)1494 567 568
WWW: http://www.janssen.co.uk
WWW: http://www.janssen-medinfo.co.uk
Medical Information Direct Line: +44 (0)800 731 8450
Medical Information e-mail: medinfo@janssen-cilag.co.uk
Customer Care direct line: +44 (0)800 731 5550

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 17/03/2011
PIL Durogesic DTrans 12/25/50/75/100 mcg/hr Transdermal Patch

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/03/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 24/01/2011 and displayed until 17/03/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 03/11/2010 and displayed until 24/01/2011
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 13/09/2010 and displayed until 03/11/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 07/09/2010 and displayed until 13/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 05/07/2010 and displayed until 07/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
Updated on 25/03/2010 and displayed until 05/07/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 19/09/2008 and displayed until 25/03/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
Updated on 04/12/2007 and displayed until 19/09/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
Updated on 06/08/2007 and displayed until 04/12/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change to dosage and administration
Updated on 14/03/2007 and displayed until 06/08/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 08/11/2006 and displayed until 14/03/2007
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change of manufacturer
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to information about drinking alcohol
  • Change to information about driving or using machinery
  • Change to how to administer the medicine
Updated on 28/11/2005 and displayed until 08/11/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  fentanyl